← Leaderboards
Michael S Yu
Johns Hopkins University
$4,793,134
Attributed
$5,974,670
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $845.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,974,670 · 7
By mechanism
R01$4,373,835 · 3
R21$1,600,835 · 4
Top collaborators
- Jeffrey A. Weiss5 shared
- Donghoon Yoon2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Xiaoqin Wang$34,711,962
- Nara Sobreira$3,895,750
- Catherine M Gordon$5,650,865
- Douglas R Stewart$365,416
- Jonathan P Schneck$20,504,328
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesCollagenPeptidesBaseAffinityCellsTechnologyExtracellular MatrixPathologicMolecularIn VivoHybridsStructureNext GenerationProteinsBindingDesignIn VitroLabelPharmaceutical PreparationsFibrosisReportingPaperDrug Delivery Systems
Grant awards (20)
Localization of Antibody Drugs to Arthritic Joints via Collagen Hybridization$354,159
R01 · FY2025 · AR · contact PI
Localization of Antibody Drugs to Arthritic Joints via Collagen Hybridization$402,086
R01 · FY2024 · AR · contact PI
Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides$355,445
R01 · FY2022 · AR
Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides$366,492
R01 · FY2021 · AR
Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides$386,952
R01 · FY2020 · AR
In situ imaging of collagen degradation activity in multiple myeloma and lung fibrosis mouse model$189,688
R21 · FY2020 · OD · contact PI
Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides$376,887
R01 · FY2019 · AR
In situ imaging of collagen degradation activity in multiple myeloma and lung fibrosis mouse model$240,000
R21 · FY2019 · OD · contact PI
Sustained Intravitreal Delivery of Ranibizumab Mediated by ECM Binding$228,750
R21 · FY2019 · EY · contact PI
Targeting Collagen Mechanical Damage using Collagen Hybridizing Peptides$447,608
R01 · FY2018 · AR
Sustained Intravitreal Delivery of Ranibizumab Mediated by ECM Binding$190,625
R21 · FY2018 · EY · contact PI
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization$335,250
R01 · FY2015 · AR · contact PI
Collagen-Targeted Therapeutics of Cathepsin Inhibitors$168,190
R21 · FY2015 · AR · contact PI
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization$328,545
R01 · FY2014 · AR · contact PI
Collagen-Targeted Therapeutics of Cathepsin Inhibitors$212,608
R21 · FY2014 · AR · contact PI
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization$301,828
R01 · FY2013 · AR · contact PI
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization$359,055
R01 · FY2012 · AR · contact PI
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization$359,528
R01 · FY2011 · AR · contact PI
Non-Covalent Modification of Collagen Scaffolds$161,007
R21 · FY2006 · GM · contact PI
Non-Covalent Modification of Collagen Scaffolds$209,967
R21 · FY2005 · GM